James A. Torchia

Also affiliated with Harvard University, Dana-Farber Cancer Institute

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Emerging concepts in PD-1 checkpoint biology”.

Emerging concepts in PD-1 checkpoint biology

Seminars in Immunology(2021)10.1016/j.smim.2021.101480

N/A

0.785DataRank · unranked

187 citations

James A. Torchia, Apoorvi Chaudhri, Arlene H. Sharpe, Gordon J. Freeman, Kristen E. Pauken

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy

Frontiers in Immunology(2023)10.3389/fimmu.2023.1237715

N/A

0.500DataRank · unranked

27 citations

Xia Bu, Yunfei Wang, Michael R. Gomez, James A. Torchia, Ping Hua +7 more

Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal Antibodies

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy(2023)10.1089/mab.2022.0037

N/A

0DataRank · unranked

1 citations

James A. Torchia, Gordon J. Freeman, Alyssa N. Klee